Consensus Clarivate Plc

Stocks

CLVT

JE00BJJN4441

Professional Information Services

Real-time Estimate Cboe BZX Other stock markets 02:46:26 18/07/26 am AEST			5-day change	1st Jan Change
2.355 ^USD	-1.87%		+6.05%	-29.19%

07/07	Healthcare Stocks Decline as Investors Rotate Away from Safety -- Healthcare Roundup	DJ
07/07	Altaris, LLC entered into a definitive agreement to acquire Life Sciences & Healthcare Business from Clarivate Plc (NYSE : CLVT) for $600 million.	CI

Evolution of the Average Target: Clarivate Plc

Evolution of the Target Price: Clarivate Plc

Changes in Analyst Recommendations: Clarivate Plc

32ea7864103.yofVt0HNRp5_XHFsyJ3QiiRW3iGma_PLTQzhWaf4xhE.svGvxxGrAdxHZD0qmNe7-xcE7GznGqaEf06Ga8ib8EOOtOGBG48C3AsQNA~db4995925289e92805087f81bb1b8a3a

Analysts' recommendations: Clarivate Plc

29/04	Clarivate Faces Q1 Segment Headwinds While Advancing Value Creation Plan, RBC Says	MT
26/02	RBC Capital Adjusts Clarivate Price Target to $3 From $5, Maintains Sector Perform Rating	MT
25/02	Analyst recommendations: IBM, Axon, Caterpillar, Fair Isaac, Gilead…
08/01	Goldman Sachs Downgrades Clarivate to Neutral From Buy, Adjusts Price Target to $3.60 From $4.20	MT
08/01	Analyst recommendations: Alphabet, Chubb, Ford, Stellantis, The Gap…
17/12	Morgan Stanley Downgrades Clarivate to Underweight From Equal Weight, Adjusts PT to $3 From $5	MT
05/12	RBC Cuts Price Target on Clarivate to $5 From $6, Keeps Sector Perform Rating	MT
29/10/25	(CLVT) Clarivate Expects 2025 Adjusted EPS Range $0.60 - $0.70, vs. FactSet Est of $0.65	MT
01/10/25	Clarivate Likely to Post In-Line Q3 Results, Reiterate FY25 Outlook, RBC Capital Says	MT
03/09/25	Wolfe Research Initiates Clarivate at Peer Perform	MT
19/07/25	Clarivate Shares Fall After Downgrade From Jefferies	MT
18/07/25	Jefferies Downgrades Clarivate to Hold From Buy, Trims Price Target to $4.50 From $5.20	MT
09/04/25	Oppenheimer Adjusts Clarivate Price Target to $6 From $7, Maintains Outperform Rating	MT
22/02/25	Global Investors Eye New Shores
21/02/25	Analyst recommendations: Alphabet, Lear Corp, Molson Coors, Hasbro, Visa...
08/11/24	Oppenheimer Adjusts Clarivate Price Target to $7 From $9, Maintains Outperform Rating	MT
08/11/24	RBC Adjusts Clarivate's Price Target to $6 From $7, Keeps Sector Perform Rating	MT
07/11/24	Analyst recommendations: Corteva, Dollar Tree, JPMorgan, Microsoft, Palantir...
07/11/24	William Blair Downgrades Clarivate to Market Perform From Outperform	MT
07/08/24	RBC Cuts Price Target on Clarivate to $7 From $8, Keeps Sector Perform Rating	MT
03/07/24	Oppenheimer Trims Price Target on Clarivate to $9 From $10, Maintains Outperform Rating	MT
10/05/24	Goldman Sachs Adjusts Price Target on Clarivate to $7.50 From $8.50, Maintains Buy Rating	MT
29/02/24	Barclays Trims Price Target on Clarivate to $6 From $7, Maintains Underweight Rating	MT
29/02/24	Oppenheimer Trims Clarivate Price Target to $10 From $11, Maintains Outperform Rating	MT
28/02/24	RBC Cuts Price Target on Clarivate to $8 From $10, Cites Limited Visibility on Second-Half Turnaround; Sector Perform Kept	MT

More recommendations

Sector Comparison:

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Analysts' Target price divergence	Objective/dr gap
CLARIVATE PLC	-	+4.17%
S&P GLOBAL, INC.		+12.74%
MSCI, INC.		+9.83%
THOMSON REUTERS CORPORATION		+24.74%
EQUIFAX INC.		+22.3%
WOLTERS KLUWER N.V.		+46.25%
COMPUTERSHARE LIMITED		-3.51%
TRANSUNION		+11.42%
FACTSET RESEARCH SYSTEMS, INC.		-3.22%
CHINA SOUTHERN POWER GRID TECHNOLOGY CO.,LTD		+50.26%
Average		+17.50%
Weighted average by Cap.		+15.38%

See all sector consensus

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

2.400USD

Average target price

2.500USD

Spread / Average Target

+4.17%

High Price Target

2.500USD

Spread / Highest target

+4.17%

Low Price Target

2.500USD

Spread / Lowest Target

+4.17%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

RBC Capital Markets
Goldman Sachs
Morgan Stanley
Wolfe Research
Jefferies & Co.
Oppenheimer
William Blair & Co.
Barclays
Wells Fargo Securities
Citigroup
BofA Securities
Stifel Nicolaus
B. Riley